Analysis of beta-tubulin gene exon 4 mutations in advanced stage III or IV gastric cancer

Tomomitsu Tahara, Tomiyasu Arisawa, Tomoyuki Shibata, Ichiro Hirata, Hiroshi Nakano

研究成果: Article

1 引用 (Scopus)

抄録

The mechanisms that cause chemoresistance of gastric cancer have yet to be elucidated. Taxanes and promising agents that were recently approved for treatment of advanced or recurrent gastric cancer. Mutations of beta-tubulin, which is a target of taxianes, have been shown to confer chemoresistance against these agents. The aim of the present study is to investigate the presence of mutations of the beta-tubulin in gastric cancer tissues. Sixty-six patients with advanced stage III or IV gastric cancer patients enrolled in this study. Paired samples of gastric cancer tissue and normal mucosa were obtained by endoscopy. The guanosine 5′-triphosphate (GTP)-binding site in exon 4 of the beta-tubulin gene was examined by polymerase chain reaction single-strand conformational polymorphism (PCR-SSCP) analysis, followed by sequencing of the products with abnormally shifted bands. SSCP analysis showed abnormal bands upstream of the GTP-binding site in 7 of the 66 patients, but sequence analysis found no nucleotide substitutions in these patients. Three variant bands were also detected down stream of the the GTP-binding site, but the sequences of the 3 products corresponded to those of two independent pseudogenes. Thus, none of the tumor samples showed mutation of the beta-tubulin exon 4 GTP-binding site. In conclusion, these findings suggest that mutations of the beta-tubulin gene are rare and are unlikely to be an important cause of taxane resistance to taxians.

元の言語English
ページ(範囲)210-215
ページ数6
ジャーナルJournal of Clinical Biochemistry and Nutrition
40
発行部数3
DOI
出版物ステータスPublished - 01-05-2007

Fingerprint

Tubulin
Guanosine
Stomach Neoplasms
Exons
Guanosine Triphosphate
Genes
Mutation
Binding Sites
Tissue
Single-Stranded Conformational Polymorphism
Taxoids
Pseudogenes
Endoscopy
Polymerase chain reaction
Polymorphism
Sequence Analysis
Tumors
Mucous Membrane
Substitution reactions
Nucleotides

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Nutrition and Dietetics
  • Clinical Biochemistry

これを引用

Tahara, Tomomitsu ; Arisawa, Tomiyasu ; Shibata, Tomoyuki ; Hirata, Ichiro ; Nakano, Hiroshi. / Analysis of beta-tubulin gene exon 4 mutations in advanced stage III or IV gastric cancer. :: Journal of Clinical Biochemistry and Nutrition. 2007 ; 巻 40, 番号 3. pp. 210-215.
@article{f740be0e4ad54a0b89229f8f09ef48ff,
title = "Analysis of beta-tubulin gene exon 4 mutations in advanced stage III or IV gastric cancer",
abstract = "The mechanisms that cause chemoresistance of gastric cancer have yet to be elucidated. Taxanes and promising agents that were recently approved for treatment of advanced or recurrent gastric cancer. Mutations of beta-tubulin, which is a target of taxianes, have been shown to confer chemoresistance against these agents. The aim of the present study is to investigate the presence of mutations of the beta-tubulin in gastric cancer tissues. Sixty-six patients with advanced stage III or IV gastric cancer patients enrolled in this study. Paired samples of gastric cancer tissue and normal mucosa were obtained by endoscopy. The guanosine 5′-triphosphate (GTP)-binding site in exon 4 of the beta-tubulin gene was examined by polymerase chain reaction single-strand conformational polymorphism (PCR-SSCP) analysis, followed by sequencing of the products with abnormally shifted bands. SSCP analysis showed abnormal bands upstream of the GTP-binding site in 7 of the 66 patients, but sequence analysis found no nucleotide substitutions in these patients. Three variant bands were also detected down stream of the the GTP-binding site, but the sequences of the 3 products corresponded to those of two independent pseudogenes. Thus, none of the tumor samples showed mutation of the beta-tubulin exon 4 GTP-binding site. In conclusion, these findings suggest that mutations of the beta-tubulin gene are rare and are unlikely to be an important cause of taxane resistance to taxians.",
author = "Tomomitsu Tahara and Tomiyasu Arisawa and Tomoyuki Shibata and Ichiro Hirata and Hiroshi Nakano",
year = "2007",
month = "5",
day = "1",
doi = "10.3164/jcbn.40.210",
language = "English",
volume = "40",
pages = "210--215",
journal = "Journal of Clinical Biochemistry and Nutrition",
issn = "0912-0009",
publisher = "The Society for Free Radical Research Japan",
number = "3",

}

Analysis of beta-tubulin gene exon 4 mutations in advanced stage III or IV gastric cancer. / Tahara, Tomomitsu; Arisawa, Tomiyasu; Shibata, Tomoyuki; Hirata, Ichiro; Nakano, Hiroshi.

:: Journal of Clinical Biochemistry and Nutrition, 巻 40, 番号 3, 01.05.2007, p. 210-215.

研究成果: Article

TY - JOUR

T1 - Analysis of beta-tubulin gene exon 4 mutations in advanced stage III or IV gastric cancer

AU - Tahara, Tomomitsu

AU - Arisawa, Tomiyasu

AU - Shibata, Tomoyuki

AU - Hirata, Ichiro

AU - Nakano, Hiroshi

PY - 2007/5/1

Y1 - 2007/5/1

N2 - The mechanisms that cause chemoresistance of gastric cancer have yet to be elucidated. Taxanes and promising agents that were recently approved for treatment of advanced or recurrent gastric cancer. Mutations of beta-tubulin, which is a target of taxianes, have been shown to confer chemoresistance against these agents. The aim of the present study is to investigate the presence of mutations of the beta-tubulin in gastric cancer tissues. Sixty-six patients with advanced stage III or IV gastric cancer patients enrolled in this study. Paired samples of gastric cancer tissue and normal mucosa were obtained by endoscopy. The guanosine 5′-triphosphate (GTP)-binding site in exon 4 of the beta-tubulin gene was examined by polymerase chain reaction single-strand conformational polymorphism (PCR-SSCP) analysis, followed by sequencing of the products with abnormally shifted bands. SSCP analysis showed abnormal bands upstream of the GTP-binding site in 7 of the 66 patients, but sequence analysis found no nucleotide substitutions in these patients. Three variant bands were also detected down stream of the the GTP-binding site, but the sequences of the 3 products corresponded to those of two independent pseudogenes. Thus, none of the tumor samples showed mutation of the beta-tubulin exon 4 GTP-binding site. In conclusion, these findings suggest that mutations of the beta-tubulin gene are rare and are unlikely to be an important cause of taxane resistance to taxians.

AB - The mechanisms that cause chemoresistance of gastric cancer have yet to be elucidated. Taxanes and promising agents that were recently approved for treatment of advanced or recurrent gastric cancer. Mutations of beta-tubulin, which is a target of taxianes, have been shown to confer chemoresistance against these agents. The aim of the present study is to investigate the presence of mutations of the beta-tubulin in gastric cancer tissues. Sixty-six patients with advanced stage III or IV gastric cancer patients enrolled in this study. Paired samples of gastric cancer tissue and normal mucosa were obtained by endoscopy. The guanosine 5′-triphosphate (GTP)-binding site in exon 4 of the beta-tubulin gene was examined by polymerase chain reaction single-strand conformational polymorphism (PCR-SSCP) analysis, followed by sequencing of the products with abnormally shifted bands. SSCP analysis showed abnormal bands upstream of the GTP-binding site in 7 of the 66 patients, but sequence analysis found no nucleotide substitutions in these patients. Three variant bands were also detected down stream of the the GTP-binding site, but the sequences of the 3 products corresponded to those of two independent pseudogenes. Thus, none of the tumor samples showed mutation of the beta-tubulin exon 4 GTP-binding site. In conclusion, these findings suggest that mutations of the beta-tubulin gene are rare and are unlikely to be an important cause of taxane resistance to taxians.

UR - http://www.scopus.com/inward/record.url?scp=34250829689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250829689&partnerID=8YFLogxK

U2 - 10.3164/jcbn.40.210

DO - 10.3164/jcbn.40.210

M3 - Article

C2 - 18398498

AN - SCOPUS:34250829689

VL - 40

SP - 210

EP - 215

JO - Journal of Clinical Biochemistry and Nutrition

JF - Journal of Clinical Biochemistry and Nutrition

SN - 0912-0009

IS - 3

ER -